Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of age and plasma concentrations of albumin and alpha 1-acid glycoprotein on protein binding of disopyramide.

Literature DB >> 6626430

Effect of age and plasma concentrations of albumin and alpha 1-acid glycoprotein on protein binding of disopyramide.

D W Holt, A M Hayler, G F Healey.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1983 PMID： 6626430 PMCID： PMC1428016 DOI： 10.1111/j.1365-2125.1983.tb02175.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

12 in total

1. Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.

Authors: P H Hinderling; E R Garrett
Journal: J Pharmacokinet Biopharm Date: 1976-06

2. The effects of urine pH and plasma protein binding on the renal clearance of disopyramide.

Authors: J L Cunningham; D D Shen; I Shudo; D L Azarnoff
Journal: Clin Pharmacokinet Date: 1977 Sep-Oct Impact factor: 6.447

3. Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

Authors: K M Piafsky; O Borgå
Journal: Clin Pharmacol Ther Date: 1977-11 Impact factor: 6.875

4. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog.

Authors: A Karim; C Kook; R L Novotney; J Zagarella; J Campion
Journal: Drug Metab Dispos Date: 1978 May-Jun Impact factor: 3.922

Review 5. Prescribing in infancy and childhood.

Authors: G Rylance
Journal: Br J Hosp Med Date: 1979-10

6. Role of concentration-dependent plasma protein binding in disopyramide disposition.

Authors: P J Meffin; E W Robert; R A Winkle; S Harapat; F A Peters; D C Harrison
Journal: J Pharmacokinet Biopharm Date: 1979-02

7. Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults.

Authors: M Ehrnebo; S Agurell; B Jalling; L O Boréus
Journal: Eur J Clin Pharmacol Date: 1971-09 Impact factor: 2.953

8. Paediatric use of mexiletine and disopyramide.

Authors: D W Holt; A C Walsh; P V Curry; M Tynan
Journal: Br Med J Date: 1979-12-08

9. Plasma binding of disopyramide.

Authors: B M David; B W Madsen; K F Ilett
Journal: Br J Clin Pharmacol Date: 1980-06 Impact factor: 4.335

10. Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein.

Authors: K M Piafsky; O Borgá; I Odar-Cederlöf; C Johansson; F Sjöqvist
Journal: N Engl J Med Date: 1978-12-28 Impact factor: 91.245

7 in total

Effect of age and plasma concentrations of albumin and alpha 1-acid glycoprotein on protein binding of disopyramide.

1. Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.

2. The effects of urine pH and plasma protein binding on the renal clearance of disopyramide.

3. Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

4. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog.

Review 5. Prescribing in infancy and childhood.

6. Role of concentration-dependent plasma protein binding in disopyramide disposition.

7. Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults.

8. Paediatric use of mexiletine and disopyramide.

9. Plasma binding of disopyramide.

10. Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein.

1. Plasma protein binding of disopyramide in pregnant and postpartum women, and in neonates and their mothers.

Review 2. Plasma protein binding of drugs in the elderly.

3. Ontogeny of plasma proteins, albumin and binding of diazepam, cyclosporine, and deltamethrin.

Review 4. Clinical pharmacokinetics of disopyramide.

Review 5. Free drug concentration monitoring in clinical practice. Rationale and current status.

6. Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide.

7. Cimetidine does not increase alpha 1-acid glycoprotein serum concentrations.